• Info
  • Insider Ownership

Insider Trading & Ownership of Caley Castelein

Location
San Francisco, CA
Summary
The estimated net worth of Caley Castelein is at least $5,681,468 dollars as of 28 Oct 2025. Caley Castelein is the Director of Whitehawk Therapeutics, Inc. and owns shares of Whitehawk Therapeutics, Inc. (WHWK) stock worth about $5.25M. Caley Castelein is the Director of ViewRay, Inc. and owns shares of ViewRay, Inc. stock worth about $435.8K.
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Caley Castelein and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Caley Castelein has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,681,468.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Whitehawk Therapeutics, Inc. ($5,245,661).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Caley Castelein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
WHWK Whitehawk Therapeutics, Inc. Director $5,245,661 12 Jun 2025
VRAYQ ViewRay, Inc. Director $435,807 19 Jul 2023
TRML Tourmaline Bio, Inc. Director $0 28 Oct 2025

Insider Transactions Reported by Caley Castelein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored